Clinical Trial Update: Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating tetracycline derivatives for cerebral arteriovenous malformations and cerebral aneurysms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Aneurysm
• Cerebral Arteriovenous Malformation

Drugs mentioned

• Tetracycline derivatives

Snippet

Sponsor: University of California, San Francisco | Conditions: Aneurysms, Arteriovenous Malformations | Phase 1 | Status: COMPLETED